| Basic Medical Informatin |
| brand name |
| Zoloft |
Cognex |
| Treatment For |
| Depression, Obsessive-compulsive Disorder, Panic Disorder, Anxiety Disorders, Post-traumatic Stress Disorder (ptsd), And Premenstrual Dysphoric Disorder (pmdd) |
Mild To Moderate Dementia Caused By Alzheimer's Disease |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| C (us) |
C (us) |
| Possible Side Effects |
| Fever, Sweating, Confusion, Fast Or Uneven Heartbeats, Agitation, Hallucinations, Fever, Overactive Reflexes, Tremors, Nausea, Vomiting, Diarrhea, Loss Of Appetite, Feeling Unsteady, Loss Of Coordination, Or Headache, Trouble Concentrating, Memory Problems, Weakness, Fainting, Seizure, Shallow Breathing |
Nausea, Vomiting, Diarrhea, Indigestion, Muscle Pain, Loss Of Appetite And Unsteadiness |
| Precautions & Contraindications |
| Hypomania And Seizure Disorders, Liver Or Kidney Damage, Heart Disease, Recent Heart Attack, Bleeding Disorders, Diabetes And Angle-closure Glaucoma |
Ulcers, Seizures, Problems With Urinary System, Asthma, Blood Vessel Problems, Heart, Kidney, Liver, Lung Or Stomach Disorders |
| Excretion |
| Renal |
Renal |
| Storage Conditions |
| 15-30°c |
15-30°c |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet |
Tablet |
| Routes (of administration) |
| Oral |
Oral, Rectal |
|
Dosage |
| 50 mg |
10 mg |
| Chemical Data |
| Bioavailability |
| 44 % |
24-36% |
| Protein binding |
| 99 % |
55 % |
| Metabolism |
| Hepatic |
Hepatic |
| Half Life (hours) |
| Approximately 26 H |
2.9-3.6 H |
| Formula |
| C17h17cl2n |
C13h14n2 |
| Molecular mass (g/mol) |
| 306.229 G/mol |
198.264 G/mol |